We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.25 | 4.00 | 4.50 | 4.25 | 4.25 | 4.25 | 255,065 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.12 | 22.67M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/2/2024 16:01 | Information Post Cavendish price target 20p Eden share price below 6p Upside 300%+++ As KittyBiscuits say's, just an information post :) | investingisatrickygame | |
24/2/2024 13:34 | Yap yap yap unfounded speculation (ie, lies) dressed up as tips, or irrelevant stuff like the Corteva appointment presented as if it has ANY BEARING WHATSOEVER on this scamstock's prospects. You c-nts and specially the shareholding one are headed for jail. ravenna23 warned you too. Painful times ahead for you cheats.............. | neutralpov | |
24/2/2024 06:12 | Inside the big Network tent. Lavie Bio 4,215 followers 3yr • We are happy and excited to announce that Frederic C. Beudot, Global Portfolio Leader for Biologicals at Corteva Agriscience™, is joining the Lavie Bio Board of directors. With extensive experience in sales, marketing, commercial and strategy of crop protection product, Frederic will allow us to further strengthen our market and commercial focus as we progress toward product launch and pipeline maturation. We are looking forward to continue the exciting journey with our board of directors – Ofer Haviv, Kristian Bjorneboe, Trevor Thiessen and Frederic C. Beudot. .............. Frederic Beudot General Manager - Biologicals Business at Corteva Agriscience | supersonico | |
23/2/2024 23:01 | Super, let's hope that one of them or ANO makes a shareholder beneficial interest in Eden!!!!!!!!!!!!! | investingisatrickygame | |
23/2/2024 21:10 | From one who follows the story; Smith @3.50m "In fact we have only collaborating with Corteva for about four years...We were introduced to a number of folks within the Corteva Europe organisation ..we identified a whole portfolio of products we could work on together".. Eden Research delivering sustainable alternative to existing seed treatments | supersonico | |
23/2/2024 20:29 | Corteva Agriscience to Invest in Evogene's Agriculture Biologicals Subsidiary, Lavie Bio Investment Includes Equity and Corteva's Shares in Taxon Biosciences for Shares in Lavie Bio NEWS PROVIDED BY Corteva, Inc. Aug 07, 2019 Corteva, Inc. (NYSE: CTVA), a leading pure-play agriculture company, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today that Corteva will make an investment in Evogene's agriculture biologicals subsidiary, Lavie Bio (Lavie). The transaction includes the exchange of all shares of Corteva's wholly owned subsidiary Taxon Biosciences along with an equity investment by Corteva in Lavie. As consideration for the Taxon Biosciences shares and equity investment, Corteva will be issued approximately 30 percent of Lavie's equity while Evogene will hold approximately 70 percent of Lavie's equity. Susanne Wasson, Crop Protection Business Platform President for Corteva Agriscience said, "This transaction demonstrates Corteva's ongoing commitment to bringing to market new and differentiated technologies for our customers." Wasson continued, "We are pleased to collaborate with Lavie Bio – a leader in the field of agriculture biologicals – as we continue to focus on accelerating commercialization of customer-centered innovation in this high-growth sector." Ofer Haviv, President & CEO of Evogene and Chairman of the Board of Lavie Bio stated, "We are extremely pleased with the combined Taxon acquisition and equity investment by Corteva, a world leader in the agricultural market, following close to two years of a co-development collaboration. By providing both additional complementary technologies along with potential go-to-market pathways, we believe this transaction will significantly enhance Lavie's capabilities for the development and commercialization of next generation agriculture biological products." Ido Dor, Lavie Bio's CEO, stated, "We are very pleased that Corteva, a world leading agricultural company, continues to partner with Lavie. I am confident that with Corteva's leadership in agriculture innovation, and the complementary capabilities which we will add through the acquisition of Taxon Biosciences, Lavie is well positioned to achieve its mission of improving food quality, agricultural sustainability and productivity through the introduction of next generation microbiome-based agriculture biological products." Agriculture biologicals include externally-applied products derived from natural, biological sources such as microbials, macrobials, biochemicals and minerals to optimize overall plant health. Agriculture biological products include bio-stimulants, for maximizing plant yield and durability, as well as bio-pesticides for insect management. The agriculture biologicals sector is a growing segment of the agriculture inputs market. Full release - | supersonico | |
23/2/2024 19:51 | Syngenta and Lavie Bio announce partnership to discover and develop novel bio-insecticide. Feb 20 2024 Agreement reinforces both companies’ commitment to developing and bringing innovative biological solutions to farmers Basel / Switzerland, and Rehovot, Israel, 20 Feb 2024 – Syngenta Crop Protection, a leader in agricultural innovation, and Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company, today announced an agreement for the discovery and development of new biological insecticidal solutions. The collaboration will leverage Lavie Bio's unique technology platform to rapidly identify and optimize bio-insecticide candidates, as well as Syngenta’s extensive global research, development and commercialization capabilities. Insects pose a major challenge to the health of crops worldwide, directly injuring plants as they feed on the plant’s stems, fruit and roots, as well as indirectly by transmitting bacterial, viral and fungal infections to crops – costing the global economy an estimated $70 billion a year, according to the UN’s Food and Agriculture Organization. Experts predict such losses will worsen with global warming widening the spread of invasive insect risk and rising resistance to available insecticides. “Syngenta is a leader in advancing sustainable agriculture and we are thrilled to collaborate with Lavie Bio in biocontrol innovation and bring novel modes of action in the growers’ toolbox to combat insect resistance,” said Camilla Corsi, Global Head of Research at Syngenta Crop Protection. “This collaboration underscores Syngenta's commitment to collaborating with cutting-edge agricultural technology companies, merging digital and experimental approaches to accelerate and diversify innovation.” "We're excited to collaborate with Syngenta, a world leader in agricultural innovation," said Amit Noam, CEO of Lavie Bio. "Both companies share a mutual commitment to sustainable farming and together, we aim to develop an impactful bio-insecticide product. Lavie Bio's unique computational capabilities and Syngenta's vast experience in developing and commercializing innovative products make this partnership significant. We enthusiastically look forward to joining forces to achieve the mutual task of insect management in agriculture." | supersonico | |
23/2/2024 15:56 | That’ll be me Tom. Don’t you worry your little grey cells about it. | kittybiscuits | |
23/2/2024 15:11 | He who laughs last.... | neutralpov | |
22/2/2024 14:59 | Oooh, touched a nerve have we. Told you before, feel free to pass my details onto the fca, pra, police, feds, even the rspca if it makes you feel better. You won’t of course, as you are just a troll. | kittybiscuits | |
21/2/2024 19:53 | He is probably the one behind this idiot, if not the same person. | kittybiscuits | |
21/2/2024 14:46 | I think S Smith you should harmonise fundamentals with the technicals . As we said at my old place "news moves markets ". | alchemy | |
21/2/2024 12:49 | There is someone, but the name escapes me ... poacher to gamekeeper vibe. Neuts has referenced him before... | timbo_slice | |
21/2/2024 11:54 | Timbo, there is no expose. There won't be one. There are no rumours. There is no FCA, investigation and the police are not raiding properties looking for evidence. It's all in his head. | kittybiscuits | |
21/2/2024 11:18 | I look forward to the expose you are preparing where these questions are answered. | timbo_slice | |
21/2/2024 10:37 | Be that as it may this seems to have become an afternoon stock . Does that mean activity in the new world has had some effects? | alchemy | |
21/2/2024 08:09 | Yes a very visible Golden Cross as foretold by observant poster yesterday | alchemy | |
21/2/2024 07:46 | Yet another series of posts where you claim to know everyone who posts here is a liar, cheat and scammer - yet all you are is a bitter, sad, loner who lost a fortune and wants revenge! | kittybiscuits | |
21/2/2024 02:28 | Cos both of you are going to the same place, though I suspect only one of you will get the full 20 years. I already know about your poor record at school and your feelings of inferiority. You got that right, at least. Now FOAD. | neutralpov |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions